|
LIXT Lixte Biotechnology Holdings Inc 1335105 |
| Income Statement |
|
Net Income
|
form10-q
|
-986,030 |
| Balance Sheet |
|
Current Assets
|
1,688,964 |
|
Assets
|
1,695,892 |
|
Current Liabilities
|
328,956 |
|
Liabilities
|
328,956 |
|
Equity
|
1,366,936 |
|
Shares Out
|
2,249,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-2,565,861 |
| Market Analysis |
Market Cap
|
4,768,721 |
|
Price
|
1.35 |
|
BVPS
|
0.61 |
|
PB
|
2.09 |
|
EPS
|
-1.83 |
|
PS
|
0.45 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view LIXT documents filed with the SEC.
LIXT Filings
Clear
